BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24300919)

  • 1. Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies.
    Bozdag M; Ferraroni M; Nuti E; Vullo D; Rossello A; Carta F; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2014 Jan; 22(1):334-40. PubMed ID: 24300919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
    Lomelino CL; Mahon BP; McKenna R; Carta F; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):976-81. PubMed ID: 26810836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
    D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
    J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
    Güzel-Akdemir O; Biswas S; Lastra K; McKenna R; Supuran CT
    Bioorg Med Chem; 2013 Nov; 21(21):6674-80. PubMed ID: 24012377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
    J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor.
    Alterio V; Tanc M; Ivanova J; Zalubovskis R; Vozny I; Monti SM; Di Fiore A; De Simone G; Supuran CT
    Org Biomol Chem; 2015 Apr; 13(13):4064-9. PubMed ID: 25733161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations.
    Wagner J; Avvaru BS; Robbins AH; Scozzafava A; Supuran CT; McKenna R
    Bioorg Med Chem; 2010 Jul; 18(14):4873-8. PubMed ID: 20598552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
    Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups.
    Bozdag M; Ferraroni M; Carta F; Vullo D; Lucarini L; Orlandini E; Rossello A; Nuti E; Scozzafava A; Masini E; Supuran CT
    J Med Chem; 2014 Nov; 57(21):9152-67. PubMed ID: 25310626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
    Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations.
    Ivanova J; Balode A; Žalubovskis R; Leitans J; Kazaks A; Vullo D; Tars K; Supuran CT
    Bioorg Med Chem; 2017 Feb; 25(3):857-863. PubMed ID: 28024887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.
    Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Supuran CT
    Chem Commun (Camb); 2012 Feb; 48(13):1868-70. PubMed ID: 22218610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
    Carradori S; De Monte C; D'Ascenzio M; Secci D; Celik G; Ceruso M; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6759-63. PubMed ID: 24189056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
    Biswas S; McKenna R; Supuran CT
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5646-9. PubMed ID: 23993330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.